TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Affibody Medical AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
194,298
|
214,389
|
277,657 |
Financial expenses |
17,282
|
16,858
|
13,300 |
Earnings before taxes |
-130,585
|
-153,001
|
-156,851 |
EBITDA |
-97,611
|
-119,318
|
-127,748 |
Total assets |
226,747
|
154,176
|
362,135 |
Current assets |
150,489
|
76,787
|
268,660 |
Current liabilities |
118,915
|
246,440
|
105,610 |
Equity capital |
-69,024
|
-148,630
|
-31 |
- share capital |
124,031
|
94,021
|
96,934 |
Employees (average) |
90
|
91
|
83 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
-30.4%
|
-96.4%
|
0.0% |
Turnover per employee |
2,159
|
2,356
|
3,345 |
Profit as a percentage of turnover |
-67.2%
|
-71.4%
|
-56.5% |
Return on assets (ROA) |
-50.0%
|
-88.3%
|
-39.6% |
Current ratio |
126.6%
|
31.2%
|
254.4% |
Return on equity (ROE) |
189.2%
|
102.9%
|
505971.0% |
Change turnover |
-35,303
|
-54,923
|
159,580 |
Change turnover % |
-15%
|
-20%
|
135% |
Chg. No. of employees |
-1
|
8
|
11 |
Chg. No. of employees % |
-1%
|
10%
|
15% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.